GlassScriptPhysician profile
Jonathan P Gentile
NPI 1558456020
$9,125.02
in general payments reported to CMS, 2019-2025
13 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,302 · 2020: $2,303 · 2021: $2,691 · 2022: $206 · 2023: $543 · 2024: $730 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,608.06 | 2019-2021 | |
| Mml US, INC. | $1,943.86 | 2021-2025 | Reactiv8 |
| Medtronic, INC. | $570.19 | 2021-2024 | Intellis Adaptivestim, Synchromedii |
| Relievant Medsystems, INC. | $534.94 | 2019-2023 | Intracept |
| Stryker Corporation | $532.64 | 2024-2025 | Mild Device Kit, Omnicurve |
| Vertos Medical, INC. | $415.72 | 2023-2024 | Mild Device Kit |
| Abbott Laboratories | $184.59 | 2021-2025 | Eterna, Octrode, Proclaim |
| Medtronic USA, INC. | $158.48 | 2020 | |
| Si-Bone, INC. | $53.85 | 2021 | |
| Boston Scientific Corporation | $52.33 | 2020-2021 | |
| Spr Therapeutics, INC | $30.17 | 2021 | |
| Inspire Medical Systems, INC. | $21.01 | 2023 | Inspire |
| Abbvie INC. | $19.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gentile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.